We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products: More products

Download Mobile App





Siemens Presents World’s First Photon-Counting CT System at Arab Health 2023

By HospiMedica International staff writers
Posted on 30 Jan 2023
Print article
Image: NAEOTOM Alpha with Quantum Technology is the world’s first photon-counting CT (Photo courtesy of Siemens)
Image: NAEOTOM Alpha with Quantum Technology is the world’s first photon-counting CT (Photo courtesy of Siemens)

Siemens Healthineers (Erlangen, Germany) is presenting its latest medical imaging innovations in healthcare, including the world’s first photon-counting CT system, at the Arab Health Exhibition & Congress taking place from 30 January – 2 February 2023 at the Dubai Convention and Exhibition Center.

At Arab Health 2023, Siemens is highlighting the NAEOTOM Alpha with Quantum Technology, the world’s first photon-counting CT, which has reinvented computed tomography. Based on the revolutionary direct signal-conversion of its QuantaMax detector, NAEOTOM Alpha offers high-resolution images at minimal dose, spectral information in every scan, and improved contrast at lower noise. Users can benefit from a never-before seen range of clinical options and breakthrough consistency – for potentially scanning previously excluded patients and confident clinical decision making.

Siemens is also showcasing the MAGNETOM Free.Max MRI system featuring the world's first 80 cm bore and a helium-free infrastructure. Also being highlighted is the MOBILETT Impact mobile digital X-ray system that brings high-quality technology to the patient’s bedside with digital imaging, wireless connectivity, and hospital system access for an undisrupted workflow experience. Among its other innovative medical imaging solutions being showcased at the event is the new ARTIS icono family of angiography systems that combines mechanical flexibility and positioning accuracy with 2k imaging and smart workflow guidance to redefine precision for interventional radiology. In addition, Siemens is highlighting its ACUSON Sequoia ultrasound system powered by BioAcoustic technology that can reduce the effects of ultrasound variability between users, patients and technology.

Siemens is also demonstrating the Atellica VTLi Patient-side Immunoassay Analyzer, powered by Magnotech Technology, that offers accurate, clinically actionable high-sensitivity troponin I testing in patients entering the ED with symptoms of a myocardial infarction (MI), right at the point of care. By producing accurate results in just 8 minutes, the Atellica VTLi Patient-side Immunoassay Analyzer can transform care delivery for millions of people each year, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories. Besides, Siemens is highlighting the epoc Blood Analysis System, a handheld, wireless solution to enable comprehensive blood analysis testing at the patient’s side on a single room temperature test card, with results in under a minute.

Related Links:
Siemens Healthineers

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Breast Imaging Workstation
SecurView

Print article

Channels

Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.